Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Cash from Operations (2018 - 2025)

Viemed Healthcare's Cash from Operations history spans 8 years, with the latest figure at 18441000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 23.05% year-over-year to 18441000.0; the TTM value through Dec 2025 reached 51916000.0, up 32.81%, while the annual FY2025 figure was 51916000.0, 32.81% up from the prior year.
  • Cash from Operations reached 18441000.0 in Q4 2025 per VMD's latest filing, roughly flat from 18367000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 18441000.0 in Q4 2025 to a low of 1175000.0 in Q1 2024.
  • Average Cash from Operations over 5 years is 9322950.0, with a median of 8313500.0 recorded in 2021.
  • Peak YoY movement for Cash from Operations: skyrocketed 662.44% in 2021, then crashed 88.81% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 8655000.0 in 2021, then decreased by 11.22% to 7684000.0 in 2022, then surged by 72.88% to 13284000.0 in 2023, then increased by 12.82% to 14987000.0 in 2024, then rose by 23.05% to 18441000.0 in 2025.
  • Per Business Quant, the three most recent readings for VMD's Cash from Operations are 18441000.0 (Q4 2025), 18367000.0 (Q3 2025), and 12254000.0 (Q2 2025).